ArticleBMC cancer2021

Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients.

Xuqi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.